Peter Whorwell

The University of Manchester

United Kingdom

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Academic Page

Research Interests

Pharmacology

30%

Pharmacotherapy

40%

Gastroenterology

80%

Mind-body Medicine

40%

Gut Health

30%

Digestive Physiology

30%

Gut Microbiota

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles15

Clinical trial

Article Link

Year:

2024

Review article: do stimulant laxatives damage the gut? A critical analysis of current knowledge

Article Link

Year:

2024

Randomised, placebo‐controlled trial and meta‐analysis show benefit of ondansetron for irritable bowel syndrome with diarrhoea: The <scp>TRITON</scp> trial

Article Link

Year:

2023

The national prevalence of disorders of gut brain interaction in the United Kingdom in comparison to their worldwide prevalence: Results from the Rome foundation global epidemiology study

Article Link

Year:

2023

A comparative study of disorders of gut–brain interaction in Western Europe and Asia based on the Rome foundation global epidemiology study

Article Link

Year:

2023

Current Practices, Experiences, and Views in Clinical Hypnosis

Article Link

Year:

2023

Face‐to‐face interviews versus Internet surveys: comparison of two data collection methods in the Rome foundation global epidemiology study: implications for population‐based research

Article Link

Year:

2023

A double-blind randomised placebo-controlled trial investigating the effects of lesogaberan on the objective cough frequency and capsaicin-evoked coughs in patients with refractory chronic cough

Article Link

Year:

2022

Double-blinded randomised placebo controlled trial of enterosgel (polymethylsiloxane polyhydrate) for the treatment of IBS with diarrhoea (IBS-D)

Article Link

Year:

2022

Patient satisfaction after remotely delivered gut-directed hypnotherapy for irritable bowel syndrome during the COVID-19 era: implications for future practice

Article Link

Year:

2022

The symptom burden of Irritable Bowel Syndrome in tertiary care during the COVID‐19 pandemic

Article Link

Year:

2022

Experience and clinical efficacy of gut-directed hypnotherapy in an Asian population with refractory irritable bowel syndrome

Article Link

Year:

2022

Hypnotherapy for irritable bowel syndrome: patient expectations and perceptions

Article Link

Year:

2022

Non-alcoholic fatty liver disease in irritable bowel syndrome

Article Link

Year:

2021

Stigma and irritable bowel syndrome

Article Link

Year:

2020

Collaborators12

Rachel Dockry

The University of Manchester

UNITED KINGDOM

Dipesh Vasant

The University of Manchester

UNITED KINGDOM

Devin Terhune

King’s College London

UNITED KINGDOM

John McLaughlin

Professor of Gastroenterology and Nutrition

The University of Manchester

UNITED KINGDOM

Donald Moss

Dean

Saybrook University

UNITED STATES

Olafur Palsson

Professor

University of North Carolina at Chapel Hill

UNITED STATES

J. Tack

BELGIUM

Syed Shariq Hasan

Honorary Clinical Senior Lecturer

Manchester University NHS Foundation Trust

UNITED KINGDOM

Phil Dinning

Professor

Flinders University

AUSTRALIA

Katalin Varga

Eötvös Loránd University

HUNGARY

Agata Mulak

Wroclaw Medical University

POLAND

Imran Aziz

Senior Lecturer and Honorary Consultant Gastroenterologist

University of Sheffield

UNITED KINGDOM

How do I reach out?

Meet Kite AI